Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019

Marissa H. Elliott · Joshua J. Skydel · Sanket Shishir Dhruva · Joseph S. Ross · Joshua David Wallach

25 citations0/0 files storedJAMA Internal Medicine

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Meta-analysis and systematic reviews Statistical Methods in Clinical Trials Statistical Methods in Epidemiology

Abstract

high-intensity care near the end of life.7 Although there are important limitations on current data regarding outcomes of IHCA for patients with COVID-19, we have enough data to conclude that it is important to implement programs to promote conversations about values and goals in the community and early goals-of-care discussions for patients hospitalized with COVID-19.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 25 citations exist upstream.

References

2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials 2008Interpreting estimates of treatment effects: implications for managed care.2012Use of relative and absolute effect measures in reporting health inequalities: structured review 2002Reporting Number Needed to Treat and Absolute Risk Reduction in Randomized Controlled Trials 2017Number needed to treat (NNT) in clinical literature: an appraisal

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.